MacroGenics Inc. Files 2024 10-K
Ticker: MGNX · Form: 10-K · Filed: Mar 20, 2025 · CIK: 1125345
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
MGNX filed its 2024 10-K. Full year results are in.
AI Summary
MacroGenics Inc. filed its 2024 10-K on March 20, 2025, reporting its fiscal year results ending December 31, 2024. The company, based in Rockville, MD, operates in the pharmaceutical preparations sector. Key financial details and business operations for the fiscal year are outlined in this comprehensive filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of MacroGenics' financial performance, strategic initiatives, and risk factors for the fiscal year 2024, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, MacroGenics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-20 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- MACROGENICS INC (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-20 (date) — Filing Date
- Rockville, MD (location) — Business Address
- James Karrels (person) — Member
- Jeffrey Peters (person) — Member
FAQ
What was MacroGenics Inc.'s total revenue for the fiscal year ending December 31, 2024?
The filing indicates revenue from collaborative agreements and product sales for the fiscal year 2024, but specific total revenue figures are not provided in this header data.
What are the primary business segments of MacroGenics Inc. as detailed in the 10-K?
The filing mentions 'productCandidate' and 'Segment' as business areas, with specific focus on 'RevenueFromCollaborativeAgreements' and 'Product' sales, and 'ContractManufacturing'.
Who are the key individuals mentioned in relation to the company's reporting for the fiscal year 2024?
James Karrels and Jeffrey Peters are mentioned as members in relation to the reporting periods.
In which state was MacroGenics Inc. incorporated?
MacroGenics Inc. was incorporated in Delaware (DE).
What is the SIC code for MacroGenics Inc.?
The Standard Industrial Classification (SIC) code for MacroGenics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 20, 2025 by James Karrels regarding MACROGENICS INC (MGNX).